1. Home
  2. GHRS vs OSBC Comparison

GHRS vs OSBC Comparison

Compare GHRS & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • OSBC
  • Stock Information
  • Founded
  • GHRS 2018
  • OSBC 1981
  • Country
  • GHRS Ireland
  • OSBC United States
  • Employees
  • GHRS N/A
  • OSBC N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • OSBC Major Banks
  • Sector
  • GHRS Health Care
  • OSBC Finance
  • Exchange
  • GHRS Nasdaq
  • OSBC Nasdaq
  • Market Cap
  • GHRS 892.0M
  • OSBC 952.7M
  • IPO Year
  • GHRS 2021
  • OSBC N/A
  • Fundamental
  • Price
  • GHRS $14.38
  • OSBC $18.51
  • Analyst Decision
  • GHRS Strong Buy
  • OSBC Buy
  • Analyst Count
  • GHRS 9
  • OSBC 4
  • Target Price
  • GHRS $30.11
  • OSBC $21.63
  • AVG Volume (30 Days)
  • GHRS 407.8K
  • OSBC 343.8K
  • Earning Date
  • GHRS 11-06-2025
  • OSBC 10-22-2025
  • Dividend Yield
  • GHRS N/A
  • OSBC 1.51%
  • EPS Growth
  • GHRS N/A
  • OSBC N/A
  • EPS
  • GHRS N/A
  • OSBC 1.48
  • Revenue
  • GHRS N/A
  • OSBC $288,832,000.00
  • Revenue This Year
  • GHRS N/A
  • OSBC $27.16
  • Revenue Next Year
  • GHRS N/A
  • OSBC $12.26
  • P/E Ratio
  • GHRS N/A
  • OSBC $12.54
  • Revenue Growth
  • GHRS N/A
  • OSBC 9.38
  • 52 Week Low
  • GHRS $6.72
  • OSBC $14.14
  • 52 Week High
  • GHRS $20.50
  • OSBC $19.46
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 55.96
  • OSBC 56.70
  • Support Level
  • GHRS $13.71
  • OSBC $17.61
  • Resistance Level
  • GHRS $15.01
  • OSBC $18.69
  • Average True Range (ATR)
  • GHRS 0.98
  • OSBC 0.47
  • MACD
  • GHRS 0.04
  • OSBC -0.01
  • Stochastic Oscillator
  • GHRS 74.17
  • OSBC 79.09

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

Share on Social Networks: